BMEA · NASDAQ · Biotechnology

Biomea Fusion (BMEA)

Develops oral small-molecule medicines for diabetes and obesity.

$1.39
vs last close−0.31 (−18.53%)

Something off on this page? Send us feedback.

Next report
Nov 3, 26
estimated · in 41 days
EPS estimate
−$0.21
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.81−$0.80−$0.51−$0.27−$0.64−$0.17−$0.12Pending
Estimate−$1.00−$0.84−$0.59−$0.26−$0.25−$0.24−$0.22−$0.21
Surprise+19.0%+4.8%+13.6%−3.8%−156.0%+29.2%+46.3%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.2MPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2028−$0.24
Sep 2028−$0.22
Jun 2028−$0.20
Mar 2028−$0.21
Dec 2027−$0.47
Sep 2027−$0.17
Jun 2027−$0.17
Mar 2027−$0.19
Dec 2026−$0.31
Nov 2026−$0.21
Aug 2026−$0.22−$0.12+46.3%
May 2026−$0.24−$0.17+29.2%
Mar 2026−$0.25−$0.64−156.0%
Nov 2025−$0.26−$0.27−3.8%
Aug 2025
May 2025
Mar 2025
Oct 2024
Jul 2024
May 2024
Apr 2024
Oct 2023
Jul 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Apr 2021
Sep 2020
Jun 2020
Mar 2020

The latest year is open to everyone — the 22 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2028−$0.24$0
Sep 2028−$0.22$0
Jun 2028−$0.20$0
Mar 2028−$0.21$0
Dec 2027−$0.47$0
Sep 2027−$0.17$0
Jun 2027−$0.17$0
Mar 2027−$0.19$0
Dec 2026−$0.31$0
Nov 3, 2026−$0.21$0
Aug 6, 2026−$0.22−$0.12+46.3%+0.8%
May 11, 2026−$0.24−$0.17+29.2%+2.0%
Mar 24, 2026−$0.25−$0.64−156.0%+0.9%
Nov 4, 2025−$0.26−$0.27−3.8%−4.6%
Aug 5, 2025
May 5, 2025
Mar 31, 2025
Oct 29, 2024
Jul 31, 2024
May 2, 2024
Apr 1, 2024
Oct 30, 2023
Jul 31, 2023
May 2, 2023
Mar 28, 2023
Nov 7, 2022
Aug 1, 2022
May 16, 2022
Feb 28, 2022
Nov 3, 2021
Aug 11, 2021
May 27, 2021
Apr 19, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020

The latest year is open to everyone — the 22 quarters behind it read with an account.